Our study quantified IL2RA mRNA expression in 239 AML excluding APL and showed that IL2RA mRNA is differentially expressed in groups classified by FLT3-ITD, CEBPADM or NPM1+FLT3-ITD− status, the recurrent genetic mutations that are prognostic relevant. This evidence concerns the gene FLT3 and acute promyelocytic leukemia.